Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Assumes Skillsoft at Perform

Oppenheimer Assumes Skillsoft at Perform

Oppenheimer analyst Ken Wong assumes Skillsoft (NYSE:SKIL) with a Perform rating.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Oppenheimer analyst Ken Wong assumes Skillsoft (NYSE:SKIL) with a Perform rating.

Morgan Stanley Initiates Coverage On Expensify with Equal-Weight Rating, Announces Price Target of $9

By Benzinga Newsdesk

January 17, 6:24 AM

Morgan Stanley analyst James Faucette initiates coverage on Expensify (NASDAQ:EXFY) with a Equal-Weight rating and announces Price Target of $9.

EXFY

News

American Resources Corporation Funds Initial Shipments Of Lithium Ores And Provides Update On Ore Processing Site Selection

By Happy Mohamed

June 27, 8:33 AM

Initial shipment of lithium ore feedstock has been funded and being shipped as part of overall offtake partnership from South African sources ReElement will develop initial processing capacity in the United States with

AREC

News

Biolase Gets Australian Therapeutic Goods Administration Approval For Its Waterlase Solid-State Dental Laser System

By Happy Mohamed

February 24, 2:28 PM

https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=405308&agid=(PrintDetailsPublic)&actionid=1

BIOL

Credit Suisse Maintains Neutral on CME Group, Lowers Price Target to $233

By Benzinga Newsdesk

July 6, 7:39 AM

Credit Suisse analyst Gautam Sawant maintains CME Group (NASDAQ:CME) with a Neutral and lowers the price target from $242 to $233.

CME

Oppenheimer Assumes Skillsoft at Perform

Related Posts

Morgan Stanley Initiates Coverage On Expensify with Equal-Weight Rating, Announces Price Target of $9

American Resources Corporation Funds Initial Shipments Of Lithium Ores And Provides Update On Ore Processing Site Selection

Biolase Gets Australian Therapeutic Goods Administration Approval For Its Waterlase Solid-State Dental Laser System

Credit Suisse Maintains Neutral on CME Group, Lowers Price Target to $233